Shanghai Kehua Bio-Engineering Co.,Ltd

¥5.11As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002022Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (12.60%)
Div yield —
ROE (23.02%)
Medical Devices
Beta (5Y) 0.37
PE TTM —
TSR TTM (21.87%)
Mkt cap ¥2.645B
ROIC (20.66%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.39
5.42%
(98.11%)
Hold 1|8|6|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.18
0.18
46.93%
43.75%
38.17%
28.29%
Revenue¥M
114.4
118.7
120.1
122.3
(1.78%)
4.87%
5.05%
4.23%
Peers (US$396.6M)
Cap (US$)
PE
406.0M
26.82x
399.6M
32.03x
394.2M
5.188x
Capital
TTM
5Y
10Y
Leveragex
1.399
4.141
2.420
EBIT/Intx
0.695
0.078
0.055
Own earn%
38.29
146.59
158.75
Sh yield%
23.64
23.43
23.55
Owners
Insiders/Inst%
0.39
63.88
Short interest%
0.56
SBC / revenue%
3.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
2